Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial
ContributorsMaitre, Thomas ; Bonnet, Maryline; Calmy, Alexandra ; Raberahona, Mihaja; Rakotoarivelo, Rivonirina Andry; Rakotosamimanana, Niaina; Ambrosioni, Juan; Miró, José M; Debeaudrap, Pierre; Muzoora, Conrad; Davis, Angharad; Meintjes, Graeme; Wasserman, Sean; Wilkinson, Robert ; Eholié, Serge; Nogbou, Frédéric Ello; Calvo-Cortes, Maria-Camilla; Chazallon, Corine; Machault, Vanessa; Anglaret, Xavier; Bonnet, Fabrice
CollaboratorsUstero Alonso, Pilar; Vazquez Pico, Patricia
Published inTrials, vol. 23, no. 1, 928
Publication date2022-11-08
First online date2022-11-08
Abstract
Keywords
- Aspirin
- HIV, High-dose rifampicin
- Linezolid
- Randomized controlled trial
- Tuberculous meningitis
- Adult
- Adolescent
- Humans
- Tuberculosis, Meningeal / diagnosis
- Tuberculosis, Meningeal / drug therapy
- HIV Infections / complications
- HIV Infections / diagnosis
- HIV Infections / drug therapy
- Rifampin
- Aspirin / therapeutic use
- South Africa / epidemiology
- Antitubercular Agents / adverse effects
- Randomized Controlled Trials as Topic
- Multicenter Studies as Topic
- Clinical Trials, Phase III as Topic
Affiliation entities
Research groups
Citation (ISO format)
MAITRE, Thomas et al. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial. In: Trials, 2022, vol. 23, n° 1, p. 928. doi: 10.1186/s13063-022-06772-1
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:173269
- DOI : 10.1186/s13063-022-06772-1
- PMID : 36348453
- PMCID : PMC9640846
ISSN of the journal1745-6215